This CC is a bad idea, IMO. NP is clearly not happy about the market’s response to the PR today and now he’s going to attempt to sell the results to the market via a CC. I personally don’t believe we’ll get any new information on the M2M data, but maybe an update on the enrollment numbers for the severe trial.